Mesalamine Delayed-Release Tablets Articles

Japan’s Zeria buys Swiss firm Tillotts for $128 million

14 September 2009

Procter & Gamble quits Rx Pharma, selling unit to Warner Chilcott for $3.1 billion

25 August 2009

Stock Commentary - New York week to Dec 15, 2008

22 December 2008

Shire's Lialda shows sustained 5-ASA release

13 October 2008

CORRECTION: P&G's Asacol trial

25 February 2008

P&G's Asacol launched in UK for UC

18 February 2008

P&G reports strong UC data on Asacol

17 December 2007

First patients recruited into trial of P&G's Asacol

3 December 2007

P&G's 800mg Asacol MR cleared in UK for acute UC and Crohn

15 October 2007

Asacol improves quality of life for UC patients

11 December 2006

S-P and Teva sign UK Mesren promotion deal

13 November 2006

Procter & Gamble's 1st-qtr EPS climbs 16%

1 November 2004

Genzyme grants P&G exclusive RDP58 licence

12 April 2004

P&G cuts further 9,600 jobs as pharma division comes under spotlight

23 March 2001

P&G's Asacol Cleared In USA

28 August 1997

Medeva Makes Swiss GI Acquisition For L10 Million

27 November 1995

SMITHKLINE ASACOL LAUNCH

25 July 1994

DIPENTUM COMPARED WITH ASACOL

1 June 1992

Showing 1-18 of 18 articles

Go to beginningPrevious
  • 1
NextGo to end